Media Coverage

Body goes here

"Part of my role as an infectious disease physician is developing certain clinical protocols," says Katya Corado, M.D., a researcher at the Lundquist Institute. "I am able to confidently provide details to our communities which have been devastated by COVID. I no longer want to see my parents, my grandparents, or my cousins dying of COVID."

Motile cilia are needed to transport ovulated eggs in the fallopian tube, according to new research.

Dr. Ashraf Ibrahim of the Lundquist Institute and Professor of Infectious Disease at UCLA explains to Ahram Online causes behind spread of mucormycosis (black fungus) across India and precautionary measures to reduce infection

Dr. Loren Miller, an infectious disease specialist at the Lundquist Institute in Torrance, is using his detective skills on the front lines of the coronavirus pandemic.

“A cautious approach to understanding the spread would be the first step before re-opening the economy,” said Dr. Loren Miller in an interview with CGTN America.

High-dose eicosapentaenoic acid may slow coronary plaque progression, but no evidence of significant regression or evaporation as of yet.

Two common hormone therapy regimens had opposite long-term effects on breast cancer incidence among postmenopausal women, according to results from two large randomized controlled Women’s Health Initiative trials presented at San Antonio Breast Cancer Symposium.

Proprietary formula shown to be effective in improving blood pressure, inflammation, and endothelial reactivity in LA Biomedical Research Institute study.

Hormone replacement therapy is a common treatment for menopause-related symptoms, and new research from the University of Pittsburgh Graduate School of Public Health reinforces the importance of tailoring hormone therapy to each patient, based on her individual risk factors for cardiovascular disease.

NBC’s Simone Boyce talks with a couple that's testing out male contraception.

Emmaus Shares Expected to Begin Trading Tomorrow on Nasdaq Under Ticker Symbol "EMMA".

The lead author of the study is Kabir Yadav, MD, MS, MSHS, Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, CA and the Los Angeles Biomedical Research Institute, Torrance, CA.

On March 25 of this year, researchers of the Los Angeles BioMed Research Institute and the University of Washington successfully completed a 28-day trial of a male birth control pill that is designed to restrict sperm production. Although the pill has not been published in a peer-reviewed journal and has yet to receive FDA approval, it may be the first step towards male hormonal contraception.

Research conducted at MSK and elsewhere has firmly established the link between excess fat and breast cancer. A major new study presented at ASCO provides the first randomized clinical trial evidence that diet can reduce postmenopausal women’s risk of dying from breast cancer.

Rowan T. Chlebowski, MD, PhD, of the Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, discusses study findings from nearly 2 decades of data, which showed a 21% reduction in deaths from breast cancer among postmenopausal women who adhered to a low-fat diet (Abstract 520).

Two new diet studies add to the evidence that when it comes to staying healthy, counting calories may not be enough. What really matters is what you choose to eat and the quality of your diet.

A balanced, low-fat diet significantly lowers the risk of dying from breast cancer in postmenopausal women, according to new long-term data from the Women’s Health Initiative (WHI) Dietary Modification trial.

A 20-year study shows a significant drop in deaths from breast cancer among women who consumed less dietary fat.

Many women swear by the effectiveness of “the pill.” These hormonal drugs can prevent unwanted pregnancies by stopping ovulation, and thus, fertilization of egg and sperm. This, in turn, could help couples make informed decisions in practicing safe sex and family planning.

Contagion® spoke to Ashraf Ibrahim, PhD, who presented the poster at the meeting, to learn more about Compound A.

The discovery was made by Nannette Yount, PhD, a consulting scientist at LA BioMed, and Michael Yeaman, PhD, a professor of medicine at the University of California, Los Angeles (UCLA), and chief of the division of molecular medicine at Harbor-UCLA Medical Center, whose role in this study was as senior investigator at LA BioMed.

The reasons it’s taken so long to develop male contraceptives are not what you think.

A male birth control pill passed early safety tests and looks promising, researchers said. But doctors noted that unknowns remain about the contraceptive – and the cultural hurdles it may face.

The testing of a new male birth control pill means we are closer to producing effective oral contraception for men. 

Men, as CNN likes to point out, have “only two” choices for birth control — condoms or a vasectomy — whereas women have so many! And gosh, are they great.

A male birth control pill passed early safety tests and looks promising, researchers said. But doctors noted that unknowns remain about the contraceptive – and the cultural hurdles it may face.

On a recent morning in Los Angeles, Michael Medrano dabbed a teaspoon-sized glob of cold gel onto his shoulders. It’s just another part of his routine these days: Brush teeth, apply deodorant, comb hair, dab gel.

[A]fter years of development, a revolutionary male contraceptive pill has passed initial stages of testing, bringing it one step closer to being a real life, viable option for family planning, and not just a fantastical concept.

Many people are looking forward to a time when men will be able to take an oral contraceptive.

But there's a challenge with hormonal birth control: suppressing testosterone in men to super-low levels while avoiding the side effects of low hormone levels, such as changes in sexual function.

A second male birth control pill succeeded in preliminary testing, suggesting that a new form of contraception may eventually exist.

The challenge has been both biological and sociological

From treating depression to helping manage alcohol addiction, researchers say legal medical “magic mushrooms” have many potential benefits.

Team hopes to improve on 85% success of first study.  First study to focus on precise controlled protein expressions via bioelectric signaling sequences intended for mature blood vessel, muscle and nerve regeneration.  

Yet another study shows that MDMA — a so-called party drug — could be a helpful component in therapy